カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

臨床試験用品の世界市場予測：製品・サービス別（製造、パッケージング、ロジスティクス、流通、保管）、フェーズ別（l、ll、lll、lV）、薬物種類別（小分子、生物製剤）、治療領域別（腫瘍、血液疾患）

【英語タイトル】Clinical Trial Supplies Market by Products & Services (Manufacturing, Packaging, Logistics, Distribution, Storage), Phases ( l, ll, lll, lV), Drug Type (Small Molecule, Biologics),Therapeutic Areas (Oncology, Blood Disorders) - Global Forecast to 2025

MarketsandMarketsが出版した調査資料（PH 3772）・商品コード：PH 3772
・発行会社（調査会社）：MarketsandMarkets
・発行日：2020年2月28日
・ページ数：159
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後24時間以内）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,650 ⇒換算￥824,900見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥970,900見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,189,900見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
MarketsandMarkets社は臨床試験用品の世界市場が、2020年17億ドルから2025年25憶ドルまで、年平均7.8％成長すると予測しています。本調査レポートでは、臨床試験用品の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場動向、サービス別（製造、パッケージング、ロジスティクス、流通、保管）分析、フェーズ別（l、ll、lll、lV）分析、薬物種類別（小分子、生物製剤）分析、治療領域別（腫瘍、神経障害＆精神障害、消化器系疾患、感染性＆免疫系疾患、血液疾患）分析、地域別分析、競争状況、企業概要などを含め、次の構成でお届け致します。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場動向
・臨床試験用品の世界市場：サービス別（製造、パッケージング、ロジスティクス、流通、保管）
・臨床試験用品の世界市場：フェーズ別（l、ll、lll、lV）
・臨床試験用品の世界市場：薬物種類別（小分子、生物製剤）
・臨床試験用品の世界市場：治療領域別（腫瘍、神経障害＆精神障害、消化器系疾患、感染性＆免疫系疾患、血液疾患）
・臨床試験用品の世界市場：地域別
・競争状況
・企業概要
❖ レポートの概要 ❖

“Increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations are driving the overall growth of the clinical trial supplies market”
The clinical trial supplies market is projected to reach USD 2.5 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 7.8%. The growth of this market is majorly driven by the increasing R&D expenditure in pharmaceutical and biopharmaceutical companies and the globalization of clinical trials & harmonization of regulations. However, the increasing cost of drug development and clinical trials is expected to restrain the growth of this market during the forecast period.

“Logistics services segment to account for the largest share of the clinical trial supplies market in 2020”
Based on service, the clinical trial supplies market is segmented into logistics; distribution, storage, and retention; packaging, labeling, and blinding; manufacturing; comparator sourcing; and solutions. The logistics services segment is expected to account for the largest share of the clinical trial supplies market during the forecast period. This can primarily be attributed to the globalization of clinical trials and the increasing number of trials involving temperature-sensitive products.

“Oncology segment to account for the largest share of the clinical trial supplies market, by therapeutic area, in 2020”
Based on the therapeutic area, the clinical trial supplies market is segmented into oncology, neurological and mental disorders, infectious and immune system diseases, digestive system diseases, blood disorders, and other therapeutic areas. The oncology segment is expected to account for the largest share of the market in 2020 and is estimated to register the highest growth during the forecast period majorly due to the high and growing number of research studies on cancer therapeutics and a large number of companies focusing on bringing innovative cancer drugs to the market.

“North America will continue to dominate the clinical trial supplies market during the forecast period”
In 2020, North America is estimated to be the largest regional market for clinical trial supplies, followed by Europe. The presence of well-established CROs and the high and growing investments in drug discovery and development by pharmaceutical and biopharmaceutical companies in North America are the major factors responsible for the large share of this region in the global market. However, the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period majorly due to the growing number of CROs in the region and the presence of less-stringent regulations for clinical trials and patient recruitment in emerging Asia Pacific countries.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 36%, Tier 2 – 45%, and Tier 3 – 19%
• By Designation: C-level – 33%, D-level – 40%, and Others – 27%
• By Region: North America – 39%, Europe – 30%, Asia Pacific – 22%, and RoW – 9%

List of Companies Profiled in the Report
• Catalent, Inc. (US)
• Almac Group (UK)
• Parexel International Corporation (US)
• Thermo Fisher Scientific, Inc. (US)
• PCI Services (US)
• UDG Healthcare Plc. (Ireland)
• Biocair (UK)
• Bilcare Limited (India)
• O&M Movianto (US)
• KLIFO A/S (Denmark)
• Capsugel (Switzerland)
• Infosys Limited (India)
• PRA Health Sciences, Inc. (US)
• Eurofins Scientific (Luxembourg)
• Marken (US)
• Seveillar Clinical Trial Supplies Pvt. Ltd. (India)
• N-SIDE (Belgium)

Research Coverage:
This report provides a detailed picture of the global clinical trial supplies market. It aims at estimating the size and future growth potential of the market across different segments, such as service, phase, drug type, therapeutic area, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall clinical trial supplies market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to position their business better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, and opportunities.

❖ レポートの目次 ❖

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. – 21)
2.1 Research Data
2.2 Secondary Data
2.2.1 Secondary Sources
2.3 Primary Data
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.4.3 Growth Forecast
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study

3 Executive Summary (Page No. – 28)

4 Premium Insights (Page No. – 32)
4.1 Market Overview
4.2 North American Market, By Drug Type & Country, 2020
4.3 Geographical Snapshot of the Market

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing R&D Expenditure in the Pharmaceutical & Biopharmaceutical Industry
5.2.1.2 Globalization of Clinical Trials and Harmonization of Regulations Resulting in the Outsourcing of Clinical Trial Activities
5.2.2 Restraints
5.2.2.1 Increasing Cost of Drug Development and Clinical Trials
5.2.3 Opportunities
5.2.3.1 Patent Expirations
5.2.3.2 Emerging Markets
5.2.3.3 Growth in the Biologics Market

6 Clinical Trial Supplies Market, By Service (Page No. – 41)
6.1 Introduction
6.2 Manufacturing
6.2.1 Manufacturing Services Include Full In-House CGMP Analytical Services, Bioanalytical Services, and Particle Characterization
6.3 Packaging, Labeling, and Blinding
6.3.1 Increasing Demand for Advanced Packaging to Support the Growth of This Market
6.4 Comparator Sourcing
6.4.1 Growing R&D Expenditure in the Pharmaceutical and Biopharmaceutical Industry to Drive Market Growth
6.5 Logistics
6.5.1 Globalization of Clinical Trials has Driven the Demand for Logistics Services
6.6 Distribution, Storage, and Retention
6.6.1 End-To-End Tracking of Drugs is an Important Factor in Clinical Trials
6.7 Solutions
6.7.1 Automation in Drug Discovery and Clinical Trials to Drive Market Growth

7 Clinical Trial Supplies Market, By Phase (Page No. – 47)
7.1 Introduction
7.2 Phase I
7.2.1 Quality of Clinical Trial Supplies and Proper Supply and Distribution Play an Important Role in the Success of a Drug in Phase I Trials
7.3 Phase II
7.3.1 Phase II Trials are Designed to Assess the EffiCACy of Drugs
7.4 Phase III
7.4.1 Involvement of a Large Number of Patients in Phase III Trials—A Major Factor Driving Market Growth
7.5 Phase IV
7.5.1 Phase IV Studies Allow Researchers to Observe the Long-Term Effects of a Particular Drug in a Considerably Larger Pool of Patients
7.6 Ba/Be Studies
7.6.1 Increasing Patent Expiration to Increase the Demand for Ba/Be Studies

8 Clinical Trial Supplies Market, By Drug Type (Page No. – 53)
8.1 Introduction
8.2 Small-Molecule Drugs
8.2.1 Ease of Development of Small-Molecule Drugs to Drive Market Growth
8.3 Biologic Drugs
8.3.1 Increasing Adoption and Affordability of Biologic Drugs to Drive Market Growth

9 Clinical Trial Supplies Market, By Therapeutic Area (Page No. – 56)
9.1 Introduction
9.2 Oncology
9.2.1 High and Growing Number of Research Studies on Cancer Therapeutics to Support Market Growth
9.3 Neurological and Mental Disorders
9.3.1 Increasing Number of Patients Suffering From Neurological Disorders is Driving Market Growth
9.4 Digestive System Diseases
9.4.1 Pharmaceutical Companies are Investing Significantly in R&D for the Development of Innovative Drugs for Digestive System Diseases
9.5 Infectious and Immune System Diseases
9.5.1 Emergence of New Infectious Diseases to Drive Market Growth
9.6 Blood Disorders
9.6.1 High Global Burden of Blood Disorders has Increased the Focus on Developing Effective Drugs
9.7 Other Therapeutic Areas

10 Clinical Trial Supplies Market, By Region (Page No. – 64)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.1.1 Availability of Advanced R&D Infrastructure has Driven the Growth of the US Market
10.2.2 Canada
10.2.2.1 Preference of Pharmaceutical Companies to Conduct Clinical Trials in Canada to Support Market Growth
10.3 Europe
10.3.1 Germany
10.3.1.1 Germany Accounted for the Largest Share of the European Market
10.3.2 UK
10.3.2.1 Favorable Government Initiatives in the UK to Support Market Growth
10.3.3 France
10.3.3.1 High Number of Oncology Clinical Trials in France to Drive Market Growth
10.3.4 Italy
10.3.4.1 High Number of Clinical Trials and the Low Drug Approval Time are the Major Factors Driving Market Growth
10.3.5 Spain
10.3.5.1 Short Study Start-Up Times and Rising R&D Expenditure to Boost the Growth of the Spanish Market
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 China
10.4.1.1 Low Cost of Clinical Trials and Large Pharmaceutical R&D Footprint in China to Drive Market Growth
10.4.2 India
10.4.2.1 Low-Cost Services and Availability of Skilled Workforce to Support Market Growth in India
10.4.3 Japan
10.4.3.1 Government Initiatives for Drug Innovation to Support Market Growth in Japan
10.4.4 Australia
10.4.4.1 Low Cost of Conducting Clinical Trials to Support Market Growth in Australia
10.4.5 Singapore
10.4.5.1 Increasing Focus of Various Companies on Singapore to Support Market Growth
10.4.6 South Korea
10.4.6.1 Government Support for Drug Innovation to Support Market Growth in South Korea
10.4.7 Rest of Asia Pacific
10.5 Rest of the World
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Other RoW Countries

11 Competitive Landscape (Page No. – 116)
11.1 Overview
11.2 Market Share Analysis, 2018
11.3 Competitive Scenario
11.3.1 Service Launches
11.3.2 Agreements and Collaborations
11.3.3 Acquisitions
11.3.4 Expansions
11.3.5 Other Developments
11.4 Competitive Leadership Mapping (2019)
11.4.1 Vendor Inclusion Criteria
11.4.2 Visionary Leaders
11.4.3 Innovators
11.4.4 Dynamic Differentiators
11.4.5 Emerging Companies

12 Company Profiles (Page No. – 122)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
12.1 Catalent, Inc.
12.2 Almac Group
12.3 Parexel International Corporation
12.4 Thermo Fisher Scientific, Inc.
12.5 PCI Services
12.6 UDG Healthcare PLC.
12.7 Biocair
12.8 Bilcare Limited
12.9 O&M Movianto (Part of Owens & Minor)
12.10 KLIFO A/S
12.11 Capsugel (Part of Lonza Group)
12.12 Infosys Limited
12.13 PRA Health Sciences, Inc.
12.14 Eurofins Scientific
12.15 Marken (A Subsidiary of UPS)
12.16 Seveillar Clinical Trial Supplies Pvt. Ltd.
12.17 N-Side
12.18 Metrics Contract Services
12.19 SIRO Clinpharm Pvt. Ltd.
12.20 CSM- Clingen Company

*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not be Captured in Case of Unlisted Companies.

13 Appendix (Page No. – 153)
13.1 Discussion Guide
13.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.3 Available Customizations
13.4 Related Reports

List of Tables (132 Tables)

Table 1 Pharmaceutical R&D Spending, By Company, 2018
Table 2 Global Cancer Incidence, 2018 Vs. 2025
Table 3 Global Incidence of the Top 10 Fatal Diseases, 2015–2017 (Million)
Table 4 Average Cost of Drugs Approved Per Year, 2004–2013
Table 5 Clinical Trial Supplies Market, By Service, 2018–2025 (USD Million)
Table 6 Market for Manufacturing Services, By Region, 2018–2025 (USD Million)
Table 7 Market for Packaging, Labeling, and Blinding Services, By Region, 2018–2025 (USD Million)
Table 8 Market for Comparator Sourcing Services, By Region, 2018–2025 (USD Million)
Table 9 Market for Logistics Services, By Region, 2018–2025 (USD Million)
Table 10 Clinical Trial Supplies Market for Distribution, Storage, and Retention Services, By Region, 2018–2025 (USD Million)
Table 11 Market for Solutions, By Region, 2018–2025 (USD Million)
Table 12 Market, By Phase, 2018–2025 (USD Million)
Table 13 Market for Phase I Trials, By Region, 2018–2025 (USD Million)
Table 14 Clinical Trial Supplies Market for Phase II Trials, By Region, 2018–2025 (USD Million)
Table 15 Market for Phase III Trials, By Region, 2018–2025 (USD Million)
Table 16 Market for Phase IV Trials, By Region, 2018–2025 (USD Million)
Table 17 Market for Ba/Be Studies, By Region, 2018–2025 (USD Million)
Table 18 Market, By Drug Type, 2018–2025 (USD Million)
Table 19 Market for Small-Molecule Drugs, By Region, 2018–2025 (USD Million)
Table 20 Market for Biologic Drugs, By Region, 2018–2025 (USD Million)
Table 21 Global Number of Clinical Trials, By Therapeutic Area (As of October 2019)
Table 22 Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 23 Clinical Trial Supplies Market for Oncology, By Region, 2018–2025 (USD Million)
Table 24 Market for Neurological and Mental Disorders, By Region, 2018–2025 (USD Million)
Table 25 Market for Digestive System Diseases, By Region, 2018–2025 (USD Million)
Table 26 Market for Infectious and Immune System Diseases, By Region, 2018–2025 (USD Million)
Table 27 Market for Blood Disorders, By Region, 2018–2025 (USD Million)
Table 28 Market for Other Therapeutic Areas, By Region, 2018–2025 (USD Million)
Table 29 Market, By Region, 2018–2025 (USD Million)
Table 30 North America: Market, By Country, 2018–2025 (USD Million)
Table 31 North America: Clinical Trial Supplies Market, By Service, 2018–2025 (USD Million)
Table 32 North America: Market, By Phase, 2018–2025 (USD Million)
Table 33 North America: Market, By Drug Type, 2018–2025 (USD Million)
Table 34 North America: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 35 Number of Clinical Trials Started in the US, By Company, 2017
Table 36 US: Market, By Service, 2018–2025 (USD Million)
Table 37 US: Market, By Phase, 2018–2025 (USD Million)
Table 38 US: Market, By Drug Type, 2018–2025 (USD Million)
Table 39 US: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 40 Number of Active Clinical Trials in Canada, By Condition (2019)
Table 41 Number of Active Clinical Trials in Canada, By Company, 2017
Table 42 Canada: Clinical Trial Supplies Market, By Service, 2018–2025 (USD Million)
Table 43 Canada: Market, By Phase, 2018–2025 (USD Million)
Table 44 Canada: Market, By Drug Type, 2018–2025 (USD Million)
Table 45 Canada: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 46 Europe: Market, By Country, 2018–2025 (USD Million)
Table 47 Europe: Market, By Service, 2018–2025 (USD Million)
Table 48 Europe: Market, By Phase, 2018–2025 (USD Million)
Table 49 Europe: Market, By Drug Type, 2018–2025 (USD Million)
Table 50 Europe: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 51 Germany: upplies Market, By Service, 2018–2025 (USD Million)
Table 52 Germany: Market, By Phase, 2018–2025 (USD Million)
Table 53 Germany: Market, By Drug Type, 2018–2025 (USD Million)
Table 54 Germany: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 55 UK: Market, By Service, 2018–2025 (USD Million)
Table 56 UK: Market, By Phase, 2018–2025 (USD Million)
Table 57 UK: Market, By Drug Type, 2018–2025 (USD Million)
Table 58 UK: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 59 Number of Clinical Trials Started in France, By Company, 2017
Table 60 France: Market, By Service, 2018–2025 (USD Million)
Table 61 France: Market, By Phase, 2018–2025 (USD Million)
Table 62 France: Market, By Drug Type, 2018–2025 (USD Million)
Table 63 France: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 64 Number of Clinical Trials Started in Italy, By Company, 2017
Table 65 Italy: Clinical Trial Supplies Market, By Service, 2018–2025 (USD Million)
Table 66 Italy: Market, By Phase, 2018–2025 (USD Million)
Table 67 Italy: Market, By Drug Type, 2018–2025 (USD Million)
Table 68 Italy: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 69 Spain: Market, By Service, 2018–2025 (USD Million)
Table 70 Spain: Market, By Phase, 2018–2025 (USD Million)
Table 71 Spain: Market, By Drug Type, 2018–2025 (USD Million)
Table 72 Spain: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 73 RoE: Market, By Service, 2018–2025 (USD Million)
Table 74 RoE: Clinical Trial Supplies Market, By Phase, 2018–2025 (USD Million)
Table 75 RoE: Market, By Drug Type, 2018–2025 (USD Million)
Table 76 RoE: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 77 Total Number of Clinical Trials in APAC, By Therapeutic Area, 2017
Table 78 APAC: Market, By Country, 2018–2025 (USD Million)
Table 79 APAC: Market, By Service, 2018–2025 (USD Million)
Table 80 APAC: Market, By Phase, 2018–2025 (USD Million)
Table 81 APAC: Market, By Drug Type, 2018–2025 (USD Million)
Table 82 APAC: Clinical Trial Supplies Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 83 China: Market, By Service, 2018–2025 (USD Million)
Table 84 China: Market, By Phase, 2018–2025 (USD Million)
Table 85 China: Market, By Drug Type, 2018–2025 (USD Million)
Table 86 China: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 87 India: Market, By Service, 2018–2025 (USD Million)
Table 88 India: Market, By Phase, 2018–2025 (USD Million)
Table 89 India: Market, By Drug Type, 2018–2025 (USD Million)
Table 90 India: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 91 Japan: Clinical Trial Supplies Market, By Service, 2018–2025 (USD Million)
Table 92 Japan: Market, By Phase, 2018–2025 (USD Million)
Table 93 Japan: Market, By Drug Type, 2018–2025 (USD Million)
Table 94 Japan: Clinical Trial Supplies Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 95 Australia: Market, By Service, 2018–2025 (USD Million)
Table 96 Australia: Market, By Phase, 2018–2025 (USD Million)
Table 97 Australia: Market, By Drug Type, 2018–2025 (USD Million)
Table 98 Australia: Clinical Trial Supplies Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 99 Singapore: Market, By Service, 2018–2025 (USD Million)
Table 100 Singapore: Market, By Phase, 2018–2025 (USD Million)
Table 101 Singapore: Market, By Drug Type, 2018–2025 (USD Million)
Table 102 Singapore: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 103 South Korea: Market, By Service, 2018–2025 (USD Million)
Table 104 South Korea: Market, By Phase, 2018–2025 (USD Million)
Table 105 South Korea: Clinical Trial Supplies Market, By Drug Type, 2018–2025 (USD Million)
Table 106 South Korea: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 107 RoAPAC: Market, By Service, 2018–2025 (USD Million)
Table 108 RoAPAC: Market, By Phase, 2018–2025 (USD Million)
Table 109 RoAPAC: Market, By Drug Type, 2018–2025 (USD Million)
Table 110 RoAPAC: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 111 RoW: Market, By Country, 2018–2025 (USD Million)
Table 112 RoW: Market, By Service, 2018–2025 (USD Million)
Table 113 RoW: Market, By Phase, 2018–2025 (USD Million)
Table 114 RoW: Market, By Drug Type, 2018–2025 (USD Million)
Table 115 RoW: Clinical Trial Supplies Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 116 Brazil: Market, By Service, 2018–2025 (USD Million)
Table 117 Brazil: Market, By Phase, 2018–2025 (USD Million)
Table 118 Brazil: Market, By Drug Type, 2018–2025 (USD Million)
Table 119 Brazil: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 120 Mexico: Market, By Service, 2018–2025 (USD Million)
Table 121 Mexico: Market, By Phase, 2018–2025 (USD Million)
Table 122 Mexico: Market, By Drug Type, 2018–2025 (USD Million)
Table 123 Mexico: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 124 Other RoW Countries: Market, By Service, 2018–2025 (USD Million)
Table 125 Other RoW Countries: Market, By Phase, 2018–2025 (USD Million)
Table 126 Other RoW Countries: Market, By Drug Type, 2018–2025 (USD Million)
Table 127 Other RoW Countries: Market, By Therapeutic Area, 2018–2025 (USD Million)
Table 128 Service Launches, 2017–2019
Table 129 Agreements & Collaborations, 2017–2019
Table 130 Acquisitions, 2017–2019
Table 131 Expansions, 2017–2019
Table 132 Other Developments, 2017–2019

List of Figures (37 Figures)

Figure 1 Research Design
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Clinical Trial Supplies Market, By Service, 2020 Vs. 2025 (USD Million)
Figure 7 Market, By Phase, 2020 Vs. 2025 (USD Million)
Figure 8 Market, By Drug Type, 2020 Vs. 2025 (USD Million)
Figure 9 Market, By Therapeutic Area, 2020 Vs. 2025 (USD Million)
Figure 10 Market, By Region, 2020 Vs. 2025 (USD Million)
Figure 11 Increasing R&D Expenditure in Pharma and Biotech Industries to Drive Market Growth
Figure 12 Small-Molecule Drugs Segment to Account for the Largest Market Share in 2020
Figure 13 China to Register the Highest Growth During the Forecast Period
Figure 14 Market: Drivers, Restraints, and Opportunities
Figure 15 R&D Spending By Phrma Member-Companies, 2001–2017 (USD Billion)
Figure 16 Number of Registered Clinical Trial Studies (Global), 2011–2018
Figure 17 Average Cost of Developing One New Approved Drug—Including the Cost of Failures
Figure 18 R&D Pipeline, By Therapy Group, 2018 & 2019
Figure 19 Total Number of Clinical Trials for Oncology, By Region (As of December 2019)
Figure 20 Total Number of Clinical Trials: Global Vs. North America
Figure 21 North America: Clinical Trial Supplies Market Snapshot
Figure 22 US: Pipeline Split of Pharma/Biotech Companies, By Phase (January 2019)
Figure 23 Number of Clinical Trials Conducted in Europe, By Country, 2018
Figure 24 Spain: Pharmaceutical R&D Expenditure, 2011–2017
Figure 25 APAC: Market Snapshot
Figure 26 Key Developments in the Market, 2017–2019
Figure 27 Global Market Share Analysis, 2018
Figure 28 Catalent, Inc.: Company Snapshot (2018)
Figure 29 Thermo Fisher Scientific, Inc.: Company Snapshot (2018)
Figure 30 UDG Healthcare: Company Snapshot (2018)
Figure 31 Bilcare Limited: Company Snapshot (2018)
Figure 32 Owens & Minor: Company Snapshot (2018)
Figure 33 Lonza Group: Company Snapshot (2018)
Figure 34 Infosys Limited: Company Snapshot (2018)
Figure 35 PRA Health Sciences, Inc.: Company Snapshot (2018)
Figure 36 Eurofins Scientific: Company Snapshot (2018)
Figure 37 UPS, Inc.: Company Snapshot (2018)



★調査レポート[臨床試験用品の世界市場予測：製品・サービス別（製造、パッケージング、ロジスティクス、流通、保管）、フェーズ別（l、ll、lll、lV）、薬物種類別（小分子、生物製剤）、治療領域別（腫瘍、血液疾患）] (コード：PH 3772)販売に関する免責事項を必ずご確認ください。
★調査レポート[臨床試験用品の世界市場予測：製品・サービス別（製造、パッケージング、ロジスティクス、流通、保管）、フェーズ別（l、ll、lll、lV）、薬物種類別（小分子、生物製剤）、治療領域別（腫瘍、血液疾患）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の臨床試験用品市場（～2027年）：サービス別（製造、包装、物流）、フェーズ別（I〜IV）、種類別（低分子、生物学的製剤）、治療領域別（腫瘍、CVD、感染症、免疫）、エンドユーザー別（製薬、バイオテクノロジー、CRO）
    PH3772-22 / MarketsandMarkets / 2022年10月24日 / MarketsandMarkets社によると、世界の臨床試験用品市場規模は、2022年36億ドルから2027年57億ドルまで年平均9.7％成長すると予測されています。本調査レポートは、臨床試験用品の世界市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、サービス別（物流＆流通、保管＆保持、包装・ラベル付け・目隠し、製造、その他）分析、フェーズ別（フェーズI、フェーズⅡ、フェーズⅢ、フェーズⅣ、その他）分析、種類別（低分子、生物学的製剤）分析、治療領域別（腫瘍、脳神経系＆精神疾患、循環器系疾患、消化器系疾患、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米）分析、競争状況などの項目を掲載しています。なお、本レポートに掲載されている企業情報には、Thermo Fisher...
  • 世界の希少疾病治験市場2023-2030：治療領域別（自己免疫・炎症、血液疾患）、フェーズ別（フェーズⅠ、フェーズⅡ、フェーズⅢ）、スポンサー別、地域別
    GRV23MR025 / Grand View Research / 2023年2月 / Grand View...
  • 世界の臨床試験供給＆物流市場2022-2030：サービス別（物流＆流通、保管＆保持）、フェーズ別、最終用途別、治療領域別、地域別
    GRV22SP059 / Grand View Research / 2022年8月23日 / Grand View...
  • 世界の小児用臨床試験市場2022-2028：フェーズ別（フェーズI、フェーズII、フェーズIII、フェーズIV）、研究別、治療領域別、地域別
    BZW22SP0046 / Bizwit Research & Consulting / 2022年6月22日 / Bizwit Research社は、2021年におよそXX百万ドルであった世界の小児用臨床試験市場規模が、2022年から2028年の間にXX％以上成長すると予測しています。本調査レポートは、小児用臨床試験の世界市場を調査対象とし、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、リスク分析（新型コロナウイルス感染症の影響）、フェーズ別（フェーズI、フェーズII、フェーズIII、フェーズIV）分析、研究別（治療研究、観察研究）分析、治療領域別（呼吸器疾患、感染症、がん、糖尿病、その他）分析、地域別状況（アメリカ、カナダ、イギリス、ドイツ、フランス、スペイン、イタリア、中国、インド、日本、オーストラリア、韓国、ブラジル、メキシコ、中東）、競争分析、調査プロセスなどの構成でまとめております。なお、参入企業情報として、ICON...

    • ◆H&Iグローバルリサーチのお客様（例）◆